Using MALDI-TOF mass spectrometry in peripheral blood for the follow up of newly diagnosed multiple myeloma patients treated with daratumumab-based combination therapy
Pharmacology, Toxicology and Pharmaceutical Science
1
4%
Business, Management and Accounting
1
4%
Computer Science
1
4%
Other
1
4%
Unknown
12
50%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 March 2021.
All research outputs
#6,448,566
of 25,387,668 outputs
Outputs from Clinica Chimica Acta
#937
of 4,795 outputs
Outputs of similar age
#152,377
of 527,330 outputs
Outputs of similar age from Clinica Chimica Acta
#7
of 41 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 4,795 research outputs from this source. They receive a mean Attention Score of 3.8. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 527,330 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.
